December 10, 2020
A Cornell-led COVID-19 patient registry, organized by Weill Cornell Medicine physicians and scientists in response to surging cases earlier this year in New York City, continues to be a source of medical insight into the workings of the novel coronavirus and treatment of infected patients. John Abbott/Weill Cornell Medicine
Dr. Monika Safford, chief of Weill Cornell Medicine’s Division of General Internal Medicine and the John J. Kuiper Professor of Medicine, was one of the co-leaders in developing the COVID-19 patient registry.
Illustrating the power of interdisciplinary cross-campus collaboration, a team of Weill Cornell Medicine physicians and scientists based in New York City, along with student statisticians collaborating remotely from Cornell’s Ithaca campus and elsewhere, have built a secure database with medical data on more than 4,000 patients who had clinical symptoms of COVID-19 and were seen at one of three NewYork-Presbyterian Hospital c
Under the terms of the deal, Harvard Pilgrim will cover whole-genome sequencing through its network of lab providers for pediatric patients meeting specific criteria.